Navigation Links
BD to Present at Investor Healthcare Conferences
Date:9/1/2009

FRANKLIN LAKES, N.J., Sept. 1 /PRNewswire-FirstCall/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a global medical technology company, announced today that it would present at the following investor healthcare conferences in September:

        Thomas Weisel Healthcare Conference 2009
        September 9, 2009
        10:55 a.m. EDT

        Morgan Stanley Global Healthcare Unplugged Conference
        September 14, 2009
        10:20 a.m. EDT

A live webcast of BD's presentations can be accessed from the BD corporate website at www.bd.com/investors. They will be available for replay for a period of seven days.

BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 28,000 people in approximately 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.

For more information, please visit www.bd.com.


'/>"/>
SOURCE BD (Becton, Dickinson and Company)
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Zimmer Holdings to Present at Upcoming Investor Conferences
2. Advanced Life Sciences to Present at 11th Annual Rodman and Renshaw Healthcare Conference
3. Volcano Corporation Presentation at Weisel Conference to be Webcast
4. China Sky One Medical, Inc. to Present at Rodman & Renshaw Annual Global Investment Conference and Conduct Non-Deal Roadshow in the U.S.
5. Clarient to Present at Upcoming Investment Conferences in New York City
6. Cumberland Pharmaceuticals to Present at UBS Global Life Sciences Conference in New York on September 21, 2009
7. Hospira Receives FDA Approval for Six New Presentations of Heparin
8. Endo Pharmaceuticals to Present at Thomas Weisel Partners Healthcare Conference 2009
9. Abbott to Present at Morgan Stanley Global Healthcare Unplugged Conference
10. VirtualScopics to Present at the Rodman & Renshaw Annual Global Investment Conference
11. Keryx Biopharmaceuticals, Inc. To Present at the Rodman & Renshaw Annual Global Investment Conference and To Hold Investor/Analyst Day
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... , ... March 24, 2017 , ... ... which will spark a conversation on the current obstacles facing infection prevention and ... completely preventable deaths caused by these infections. , The print component of ...
(Date:3/24/2017)... ... March 24, 2017 , ... Texas Physical Therapy Specialists (TexPTS) ... at 9618 Huebner Road. The clinic is the group’s 7th location in San Antonio ... Ali Higgins, PT, will provide care from the clinic, which opened March 22, 2017. ...
(Date:3/24/2017)... ... March 24, 2017 , ... As the standards bearer of ... platform that positions them as the go-to thought leader in all matters concerning ... as an always-on, always-fresh news, views and advocacy engine, called ONS Voice. , ...
(Date:3/24/2017)... ... 24, 2017 , ... Gastro Health (“GH”) ( http://www.gastrohealth.com ... for colonoscopy at the HyGIeaCare® Center that is to be located adjacent to ... , The HyGIeaCare® Prep, cleared by the U.S. Food and Drug Administration (FDA), ...
(Date:3/24/2017)... (PRWEB) , ... March 24, 2017 , ... “Vintage and ... a retired minister and college Bible teacher residing in North Carolina with his wife, ... who have blessed them with six grandchildren. David is also the author of “Shadow ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... ShangPharma, a leading life science ... development and discovery services, technology, and investment ... today the intent for a strategic corporate ... the Contract Research Organizations (CRO) and Contract ... entities include ChemPartner Shanghai, ChemPartner Fengxian, ChemPartner ...
(Date:3/24/2017)... , March 24, 2017 A ReportsnReports.com report ... been growing rapidly as the global sales of Adcetris and Kadcyla ... in the antibody drug conjugates market is driven by large number ... and wider therapeutic window offered by ADCs. ... Browse 3 Tables and 94 Figures, 10 ...
(Date:3/24/2017)... , March 24, 2017  Eli Lilly ... announced plans to invest $850 million in its ... facilities across its U.S. enterprise, including research laboratories, ... investments are being driven by demand for Lilly ... potential medicines in development targeting cancer, pain, diabetes ...
Breaking Medicine Technology: